What's in AJENAT PHARMS's pipeline?

AJENAT PHARMS has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with AJENAT PHARMS's portfolio?

Top competitors by shared drug class: Assaf-Harofeh Medical Center, Azienda Ospedaliera Universitaria Policlinico "G. Martino", B.P. Koirala Institute of Health Sciences, Bausch Health, Centro Medico Nacional La Raza, IMSS.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ajenat-pharms.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

AJENAT PHARMS — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AJENAT PHARMS pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tranxene	clorazepate	marketed	Benzodiazepine	GABA-A receptor alpha-1/beta-2/gamma-2	Neuroscience	1972-01-01
Desoxyn	METHAMPHETAMINE	marketed	Amphetamine Anorectic	Sodium-dependent noradrenaline transporter	Metabolic	1943-01-01

Therapeutic area mix

Metabolic · 1
Neuroscience · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assaf-Harofeh Medical Center · 1 shared drug class
Azienda Ospedaliera Universitaria Policlinico "G. Martino" · 1 shared drug class
B.P. Koirala Institute of Health Sciences · 1 shared drug class
Bausch Health · 1 shared drug class
Centro Medico Nacional La Raza, IMSS · 1 shared drug class
Chang Gung Memorial Hospital · 1 shared drug class
Consorci Sanitari de l'Anoia · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for AJENAT PHARMS:

Cite this brief

Drug Landscape (2026). AJENAT PHARMS — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ajenat-pharms. Accessed 2026-06-10.